Prodrug
Showing 1 - 25 of 485
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten, Xeruborbactam Oral Prodrug Placebo)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- +3 more
- (no location specified)
Oct 6, 2023
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- Ceftibuten
- (no location specified)
Nov 27, 2023
Malignant Glioma, Recurrent Ependymoma Trial in Chicago, Boston (biological, drug, radiation)
Completed
- Malignant Glioma
- Recurrent Ependymoma
- AdV-tk
- +2 more
-
Chicago, Illinois
- +1 more
Oct 26, 2021
Advanced Solid Tumors Trial in Pittsburgh (Stereotactic Body Radiotherapy (SBRT), navoximod, NLG802 (indoximod Prodrug))
Not yet recruiting
- Advanced Solid Tumors
- Stereotactic Body Radiotherapy (SBRT)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 18, 2022
Cancer, Gastro-Intestinal Intraepithelial Neoplasia Trial in Jerusalem (Promitil)
Active, not recruiting
- Cancer
- Gastro-Intestinal Intraepithelial Neoplasia
-
Jerusalem, IsraelShaare Zedek Medical Center
Dec 21, 2022
Healthy Volunteers Trial in Honolulu (PRX-P4-003, (-)-FCF)
Completed
- Healthy Volunteers
- PRX-P4-003, (-)-FCF
-
Honolulu, HawaiiHawaii Pacific Neuroscience
Nov 9, 2021
Recreational Drug Use Trial in Overland Park (PF614, Oxycodone Hydrochloride 40 mg, Placebo)
Completed
- Recreational Drug Use
- PF614
- +2 more
-
Overland Park, KansasDr. Vince Clinical Research
Jan 3, 2023
Recurrent T Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia Trial in United States (AKR1C3-activated
Active, not recruiting
- Recurrent T Acute Lymphoblastic Leukemia
- Refractory T Acute Lymphoblastic Leukemia
- AKR1C3-activated Prodrug OBI-3424
-
Birmingham, Alabama
- +113 more
Jan 24, 2023
Healthy Volunteers Trial in Salt Lake City (PF614, Naltrexone Hydrochloride, OxyContin)
Recruiting
- Healthy Volunteers
- PF614
- +2 more
-
Salt Lake City, UtahPRA Health Sciences-Early Development Services
Sep 19, 2021
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Malignant Tumor in the Brain Trial in United States
Suspended
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Laboratory Biomarker Analysis
- +4 more
-
La Jolla, California
- +13 more
Jul 16, 2022
Advanced Cancer Trial in Canada, United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral, Capecitabine, 5-fluorouracil prodrug;
Completed
- Advanced Cancer
- ARRY-334543, EGFR/ErbB2 inhibitor; oral
- Capecitabine, 5-fluorouracil prodrug; oral
-
Aurora, Colorado
- +3 more
Oct 2, 2020
Kidney Cancer, Liver Cancer Trial in Scottsdale, Rochester (hypoxia-activated prodrug TH-302, sorafenib tosylate)
Completed
- Kidney Cancer
- Liver Cancer
- hypoxia-activated prodrug TH-302
- sorafenib tosylate
-
Scottsdale, Arizona
- +1 more
Feb 4, 2020
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin Trial in Australia, United States (TH-4000)
Terminated
- Metastatic Head-and-neck Squamous-cell Carcinoma
- TH-4000 (Tarloxotinib)
-
Los Angeles, California
- +9 more
Jan 9, 2023
Parkinson Disease Trial in Ann Arbor (tributyrin)
Recruiting
- Parkinson Disease
-
Ann Arbor, MichiganUniversity of Michigan Health System Functional Neuroimaging, Co
Sep 13, 2022
Naldebain® Extended-release Injection After Cesarean Section in
Not yet recruiting
- Post Operative Pain
- +2 more
- Dinalbuphine sebacate
- (no location specified)
Jun 30, 2022
Solid Tumor Trial (CP-506, Carboplatin, Immune checkpoint inhibitor)
Not yet recruiting
- Unspecified Adult Solid Tumor, Protocol Specific
- CP-506
- +2 more
- (no location specified)
Jun 23, 2022
Influenza, Human Trial in Shanghai (ZX-7101A, Placebo)
Not yet recruiting
- Influenza, Human
- ZX-7101A
- Placebo
-
Shanghai, Shanghai, ChinaHuashan Hospital affiliated to Fudan University
Jul 20, 2023
